Increased Dose-Intensity in Small-Cell Lung Cancer: A Failed Strategy?-Reference-Cited by-同舟云学术

Increased Dose-Intensity in Small-Cell Lung Cancer: A Failed Strategy?

Published:1999-08 Issue:8 Volume:17 Page:2297-2297
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Johnson David H.¹,Carbone David P.¹

Affiliation:

1. Division of Hematology and Oncology, Department of Medicine, Vanderbilt University School of Medicine, The Vanderbilt-Ingram Cancer Center, Nashville, TN

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.1999.17.8.2297

Reference18 articles.

1. DeVita VT: The James Ewing Lecture: The relationship between tumor mass and resistance to chemotherapy—Implications for surgical adjuvant treatment of cancer. Cancer 51:1207,1983-1220,

2. Cohen MH, Creaven PJ, Fossieck BE, et al: Intensive chemotherapy of small cell bronchogenic carcinoma. Cancer Treatment Rep 61:349,1977-354,

3. Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer.

4. A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.

5. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer;Cell Death & Disease;2014-02

2. Das kleinzellige Bronchialkarzinom;Wiener klinische Wochenschrift;2007-12

3. Das kleinzellige Bronchialkarzinom – neue Entwicklungen nach ASCO 2007;Wiener Medizinische Wochenschrift;2007-11

4. Small cell lung cancer (CPC) - Small cell bronchial carcinoma: therapeutic management;REV MAL RESPIR;2006

5. The Insulin-Like Growth Factor-I Receptor Kinase Inhibitor, NVP-ADW742, Sensitizes Small Cell Lung Cancer Cell Lines to the Effects of Chemotherapy;Clinical Cancer Research;2005-02-15